Search Results 691-700 of 2610 for Hepatitis b

1. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Active hepatitis B or C with uncontrolled disease. Note: a detailed assessment of hepatitis B/C medical history and risk factors must be done at screening ...

2. A Study to Evaluate Entolimod on Immune System Aging in Healthy Geriatric Subjects Receiving Influenza Vaccination - Mayo Clinic

   The purpose of this study is to measure changes of the anti- A/H1N1, anti-A/H3N2, and anti-B ... Positive hepatitis B surface antigen (HBsAg) and negative ...

3. Clinical Trials - TD-1473 for Active Ulcerative Colitis (UC)

   ... hepatitis B surface antibody or detectable serum hepatitis B DNA. Has clinically significant abnormalities in laboratory evaluations; Participated in another ...

4. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

   ... hepatitis B virus (HBV):. Subjects who are hepatitis B surface antigen (HBsAg) negative and HBV viral DNA negative are eligible;; Subjects who had hepatitis B ...

5. Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell Lymphoma - Mayo Clinic

   History of human immunodeficiency virus (HIV) infection or acute or chronic active hepatitis B or C infection. Subjects with history of hepatitis infection ...

6. Surgery - Doctors - Mayo Clinic

   problems, Esophageal varices, Hepatitis C, Primary sclerosing cholangitis, Hepatitis B, Cholangiocarcinoma, Portal hypertension, Hemochromatosis, Alcoholic ...

7. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

   Subject who is seropositive for or active viral infection with hepatitis B virus (HBV) (hepatitis B surface antigen [HBsAg] positive and/or detectable viral DNA) ...

8. Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies - Mayo Clinic

   History of active hepatitis or positive serology for hepatitis. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

9. Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma - Mayo Clinic

   No active viral infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C. Those who are seropositive (e.g., hepatitis B core antibody ...

10. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...